Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an antiestrogen in breast tissue.
It is widely used in the treatment of estrogen receptor-positive (ER+) breast cancer, blocking estrogen-mediated tumor growth.
Tamoxifen exhibits agonistic effects in bone and uterus while antagonizing estrogen receptors in breast tissue.